Cited by 1,410Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement DisordersDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 87 of the 88 references it cites were found in a registry or an index; 10 of the 122 sources its claims cite were checked for support.

The clinical symptoms of Parkinson's disease.

Open access
Sveinbjornsdottir, Sigurlaug·2016·Journal of Neurochemistry

Abstract

A review describing both motor and non-motor clinical features of Parkinson's disease in the context of disease progression.

Overview

Integrity signals

Registry

Crossref · 10.1111/jnc.13691

Cites

87 of 87 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

10 of 122 cited sources checked · 8 supported · 0 flagged · accuracy not yet measured

Show all 72 claims

  • Probably not a substantial claim. 15
  • It may state two separate claims as one. 32
44 of 44
  • The paper relies on this without support.

    Parkinson's disease is usually diagnosed by the first motor symptoms.

    “The disease is usually diagnosed by the first motor symptoms.”
  • The paper relies on this without support.

    Postural deformities are a frequent complication of Parkinson's disease.

    “Postural deformities are a frequent complication of Parkinson's disease.”
  • The paper relies on this without support.

    The pathophysiology of postural deformities in Parkinson's disease may be multifactorial and probably includes rigidity, axial dystonia, myopathy and centrally impaired proprioception.

    “The pathophysiology of these deformities may be multifactorial and probably includes rigidity, axial dystonia, myopathy and centrally impaired proprioception.”
  • The paper relies on this without support.

    In one study of 109 recently diagnosed Parkinson's disease patients not yet started treatment, symptoms such as apathy, excessive daytime sleepiness, sleep problems and constipation may occur in up to 60-70% prior to diagnosis and were more common than in normal controls.

    “One study of 109 recently diagnosed patients who had not yet started treatment showed that symptoms such as a lack of emotional involvement and interest (apathy), excessive daytime sleepiness, sleep problems and constipation may occur in up to 60-70% of patients prior to the diagnosis and these symptoms were more common than in normal controls.”
  • The paper relies on this without support.

    With advancing disease, non-motor symptoms generally become more troublesome for patients than motor symptoms in Parkinson's disease.

    “With advancing disease, the non-motor symptoms generally become more troublesome for the patients than the motor symptoms.”
  • The paper relies on this without support.

    Orthostatic hypotension affects 30-40% of Parkinson's disease patients.

    “Orthostatic hypotension affects 30-40% of patients.”
  • The paper relies on this without support.

    Anxiety and depression in Parkinson's disease may disappear with dopaminergic treatment, but may be persistent or recur in the long clinical course of the disease.

    “Anxiety and depression may disappear with dopaminergic treatment, but may be persistent or recur in the long clinical course of the disease.”
  • The paper relies on this without support.

    The aetiology of Parkinson's disease is probably multifactorial and there is no available treatment that will halt or stop progression of the disease.

    “The aetiology of PD is probably multifactorial and there is no available treatment that will halt or stop progression of the disease.”
  • The paper relies on this without support.

    Levodopa is standard and the most common initial therapy for Parkinson's disease patients.

    “Levodopa, a prodrug to dopamine, is standard and the most common initial therapy for patients.”
  • The paper relies on this without support.

    Early on, response to levodopa is usually good in Parkinson's disease.

    “Early on, response is usually good.”
  • The paper relies on this without support.

    With disease progression, the majority of Parkinson's disease patients experience shorter duration of response to individual doses (wearing-off), on-off symptoms, dyskinesias and other motor complications.

    “With disease progression and less capacity of the system to store dopamine, the majority of patients experience shorter duration of response to individual doses (wearing-off symptoms), alternative phases with good and poor response to medication (on-off symptoms), involuntary movements of the head, trunk or limbs (dyskinesias) and other motor complications.”
  • The paper relies on this without support.

    Parkinson's disease is a progressive multi-system neurodegenerative disease affecting people mainly in later years of life.

    “Parkinson's disease (PD) is a progressive multi-system neurodegenerative disease affecting people mainly in later years of life.”
12 of 12

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 88 references

1 of the 88 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. 10.1007/s00415-003-1105-z · DOI · Paper page

Cited by

Sorted by citations

Items 1,001–1,100 of 1,401

Metadata

Authors
Sveinbjornsdottir, S.
Affiliations
Department of Neurology Broomfield Hospital Chelmsford Essex CM1 7ET UK
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2016-07-11
Volume
139
Issue
S1
Pages
318-324
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W2464977649
Cited by
1,410
References
88
Citations by year
2026: 108 · 2025: 182 · 2024: 201 · 2023: 202 · 2022: 167 · 2021: 182 · 2020: 128 · 2019: 118 · 2018: 67 · 2017: 46 · 2016: 4
FWCI
10.88
Type
journal article
Language
en
Open access
Locations
  • Journal of Neurochemistry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
Parkinson's disease, motor symptoms, non-motor symptoms, disease progression, neurodegeneration, orthostatic hypotension, constipation, sleep disorders, neuropsychiatric symptoms, autonomic dysfunction, tremor, Parkinson's disease treatment, treatment complications
MeSH terms
Animals, Mental Disorders, Humans, Parkinson Disease, Sleep Wake Disorders, Tremor, Disease Progression, Gait Disorders, Neurologic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review